MedTrace Logo

Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology

NCT02220556 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2025-08-08

No results posted yet for this study

Summary

Fifteen cohorts will be opened. Each cohort will explore one analysis method and/or tumoral type. Up to 50 patient can be included into each cohort.

Conditions

  • Solid Tumor, Adult

Interventions

PROCEDURE

Blood sampling

Sponsors & Collaborators

  • Institut Curie

    lead OTHER

Principal Investigators

  • Jean-Yves Pierga, Prof. · Institut Curie

  • François-Clément Bidard, MD, PhD · Institut Curie

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02220556 on ClinicalTrials.gov